Genome’s dark matter offers clues to major challenge in prostate cancer

Researchers identified a novel gene they named ARLNC1 that controls signals from the androgen receptor, a key player in prostate cancer. Knocking down this long non-coding RNA in mice led to cancer cell death, suggesting this may be a key target for future therapies. (Mehr in: Cancer News — ScienceDaily)